Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The effects of a cyclo-oxygenase II inhibitor on placental artery production of thromboxane and prostacyclin.

Howard BC, Kovac CM, Calhoun BC, Hoeldtke NJ, Napolitano PG.

Am J Obstet Gynecol. 2003 Sep;189(3):835-8.

PMID:
14526325
2.

Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries.

Thorp JA, Walsh SW, Brath PC.

Am J Obstet Gynecol. 1988 Dec;159(6):1381-4.

PMID:
3061295
3.

Cocaine alters placental production of thromboxane and prostacyclin.

Monga M, Chmielowiec S, Andres RL, Troyer LR, Parisi VM.

Am J Obstet Gynecol. 1994 Oct;171(4):965-9.

PMID:
7943110
4.

Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.

Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM.

Br J Pharmacol. 2001 Apr;132(7):1565-73.

5.

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.

PMID:
14564311
6.
7.

Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers.

McAdam BF, Byrne D, Morrow JD, Oates JA.

Circulation. 2005 Aug 16;112(7):1024-9. Epub 2005 Aug 8.

PMID:
16087791
10.

[Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].

Kong WX, Ma J, Gu Y, Yang HC, Zuo YQ, Lin SY.

Zhonghua Nei Ke Za Zhi. 2003 Mar;42(3):186-90. Chinese.

PMID:
12816702
11.

Biomedicine. Back to an aspirin a day?

Vane JR.

Science. 2002 Apr 19;296(5567):474-5. No abstract available.

PMID:
11964462
12.

Coxibs and cardiovascular disease.

Fitzgerald GA.

N Engl J Med. 2004 Oct 21;351(17):1709-11. Epub 2004 Oct 6. No abstract available.

13.

Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men.

Tuleja E, Mejza F, Cmiel A, Szczeklik A.

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1111-5. Epub 2003 May 1.

PMID:
12730088
14.

A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.

Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1509-15.

PMID:
11185674
15.

Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.

Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH, Terry E, Morrow JD, Coffey RJ.

Cancer Res. 2003 Apr 15;63(8):1748-51.

16.

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

Patrono C, Patrignani P, García Rodríguez LA.

J Clin Invest. 2001 Jul;108(1):7-13. Review. No abstract available.

17.

Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries.

Bolla M, You D, Loufrani L, Levy BI, Levy-Toledano S, Habib A, Henrion D.

Hypertension. 2004 Jun;43(6):1264-9. Epub 2004 Apr 19.

18.
19.

Effects of angiogenic growth factors on endothelium-derived prostacyclin production by ovine uterine and placental arteries.

Krishnamurthy P, Bird IM, Sheppard C, Magness RR.

Prostaglandins Other Lipid Mediat. 1999 Jan;57(1):1-12.

PMID:
10367292
20.

Luminal release of prostacyclin and thromboxane A2 by arteries distal to small-caliber prosthetic grafts.

Bush HL Jr, Jakubowski JA, Hong SL, McCabe M, Deykin D, Nabseth DC.

Circulation. 1984 Sep;70(3 Pt 2):I11-5.

PMID:
6430592

Supplemental Content

Support Center